Girijax Pharmacheuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 18-12-2024
- Paid Up Capital ₹ 0.10 M
as on 18-12-2024
- Company Age 3 Year, 3 Months
About Girijax Pharmacheuticals
The Company is engaged in the Chemicals Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Alok Upadhyay, Harsh Sharma, Preeti Singla, and One other member serve as directors at the Company.
- CIN/LLPIN
U24299UP2021PTC153468
- Company No.
153468
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Oct 2021
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Bareilly, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Girijax Pharmacheuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nishi Upadhyay  | Managing Director | 07-Oct-2021 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Preeti Singla | Director | 07-Oct-2021 | Current |
| Alok Upadhyay | Director | 07-Oct-2021 | Current |
| Harsh Sharma | Director | 07-Oct-2021 | Current |
Financial Performance of Girijax Pharmacheuticals.
Enhance accessibility to Girijax Pharmacheuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Girijax Pharmacheuticals?
Unlock access to Girijax Pharmacheuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Harshly Innovative Engineering Private LimitedActive 9 years 2 monthsAlok Upadhyay and Nishi Upadhyay are mutual person
- Harshly Education And Skills Technologies Private LimitedActive 3 years 4 months
Alok Upadhyay, Harsh Sharma and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Girijax Pharmacheuticals?
Girijax Pharmacheuticals has a workforce of 0 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Girijax Pharmacheuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Girijax Pharmacheuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
